184 related articles for article (PubMed ID: 25356814)
1. Serum YKL-40 is increased in patients with slow coronary flow.
Xu Y; Meng HL; Su YM; Chen C; Huang YH; Li XF; Fan MK; Yan YJ; Wu J; Jiang MH; Pan M
Coron Artery Dis; 2015 Mar; 26(2):121-5. PubMed ID: 25356814
[TBL] [Abstract][Full Text] [Related]
2. The relationship between neutrophil gelatinase-associated lipocalin levels and the slow coronary flow phenomenon.
Aksan G; Soylu K; Aksoy O; Özdemir M; Yanik A; Yuksel S; Gedikli Ö; Gulel O; Sahin M
Coron Artery Dis; 2014 Sep; 25(6):505-9. PubMed ID: 24801557
[TBL] [Abstract][Full Text] [Related]
3. Increased Platelet to Lymphocyte Ratio is Related to Slow Coronary Flow.
Akboga MK; Canpolat U; Balci KG; Akyel A; Sen F; Yayla C; Cay S; Aras D; Aydogdu S
Angiology; 2016 Jan; 67(1):21-6. PubMed ID: 25725035
[TBL] [Abstract][Full Text] [Related]
4. Increased circulating soluble CD40 levels in patients with slow coronary flow phenomenon: an observational study.
Durakoğlugil ME; Kocaman SA; Çetin M; Kirbaş A; Canga A; Erdoğan T; Çiçek Y
Anadolu Kardiyol Derg; 2013 Feb; 13(1):39-44. PubMed ID: 23070634
[TBL] [Abstract][Full Text] [Related]
5. [Effects of Guizhi Fuling Decoction on YKL-40 and hs-CRP of patients with non-ST segment elevation acute coronary syndrome].
Pei Q; Sang WF; Zhao XD
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Feb; 33(2):186-90. PubMed ID: 23646472
[TBL] [Abstract][Full Text] [Related]
6. Increased serum resistin levels in patients with coronary slow-flow phenomenon.
Canga A; Cetin M; Kocaman SA; Durakoğlugil ME; Kırbaş A; Erdoğan T; Temiz A; Yılmaz A; Ciçek Y
Herz; 2013 Nov; 38(7):773-8. PubMed ID: 23400345
[TBL] [Abstract][Full Text] [Related]
7. Increased epicardial adipose tissue in patients with slow coronary flow phenomenon.
Erdogan T; Canga A; Kocaman SA; Cetin M; Durakoglugil ME; Cicek Y; Ugurlu Y; Bozok S
Kardiol Pol; 2012; 70(9):903-9. PubMed ID: 22992998
[TBL] [Abstract][Full Text] [Related]
8. Acute phase reactants in patients with coronary slow flow phenomenon.
Madak N; Nazlı Y; Mergen H; Aysel S; Kandaz M; Yanık E; Cekdemir D; Tavlı T
Anadolu Kardiyol Derg; 2010 Oct; 10(5):416-20. PubMed ID: 20929698
[TBL] [Abstract][Full Text] [Related]
9. Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial.
Harutyunyan M; Gøtze JP; Winkel P; Johansen JS; Hansen JF; Jensen GB; Hilden J; Kjøller E; Kolmos HJ; Gluud C; Kastrup J
Immunobiology; 2013 Jul; 218(7):945-51. PubMed ID: 23294528
[TBL] [Abstract][Full Text] [Related]
10. Increased YKL-40 levels in patients with isolated coronary artery ectasia: an observational study.
Erdoğan T; Kocaman SA; Çetin M; Durakoğlugil ME; Kırbaş A; Canga A; Yılmaz A; Doğan S; Çiçek Y
Anadolu Kardiyol Derg; 2013 Aug; 13(5):465-70. PubMed ID: 23728225
[TBL] [Abstract][Full Text] [Related]
11. Serum Salusin-β Levels Are Correlated with Slow Coronary Flow.
Wang T; Dong AH; Cao HY
Genet Test Mol Biomarkers; 2016 Jul; 20(7):393-7. PubMed ID: 27227272
[TBL] [Abstract][Full Text] [Related]
12. Novel inflammatory marker in dialysis patients: YKL-40.
Okyay GU; Er RE; Tekbudak MY; Paşaoğlu Ö; Inal S; Öneç K; Paşaoğlu H; Altok K; Derici Ü; Erten Y
Ther Apher Dial; 2013 Apr; 17(2):193-201. PubMed ID: 23551676
[TBL] [Abstract][Full Text] [Related]
13. Increased high sensitive CRP level and its significance in pathogenesis of slow coronary flow.
Barutcu I; Sezgin AT; Sezgin N; Gullu H; Esen AM; Topal E; Ozdemir R; Kosar F; Cehreli S
Angiology; 2007; 58(4):401-7. PubMed ID: 17652225
[TBL] [Abstract][Full Text] [Related]
14. Association of Monocyte-to-HDL Cholesterol Ratio with Slow Coronary Flow is Linked to Systemic Inflammation.
Canpolat U; Çetin EH; Cetin S; Aydin S; Akboga MK; Yayla C; Turak O; Aras D; Aydogdu S
Clin Appl Thromb Hemost; 2016 Jul; 22(5):476-82. PubMed ID: 26139836
[TBL] [Abstract][Full Text] [Related]
15. The Relationship between Interleukin-6 Promotor Polymorphisms and Slow Coronary Flow Phenomenon.
Liu CL; Xue ZQ; Gao SP; Chen C; Chen XH; Pan M; Wang ZX
Clin Lab; 2016; 62(5):947-53. PubMed ID: 27349023
[TBL] [Abstract][Full Text] [Related]
16. Chitinase-3-Like Protein 1 (YKL-40) Is a New Biomarker of Inflammation in Psoriasis.
Salomon J; Matusiak Ł; Nowicka-Suszko D; Szepietowski JC
Mediators Inflamm; 2017; 2017():9538451. PubMed ID: 28932021
[TBL] [Abstract][Full Text] [Related]
17. Plasma YKL-40 and recovery of left ventricular function after acute myocardial infarction.
Hedegaard A; Ripa RS; Johansen JS; Jørgensen E; Kastrup J
Scand J Clin Lab Invest; 2010 Apr; 70(2):80-6. PubMed ID: 20102300
[TBL] [Abstract][Full Text] [Related]
18. Serum YKL-40 for monitoring myocardial ischemia after revascularization in patients with stable coronary artery disease.
Harutyunyan M; Johansen JS; Mygind ND; Reuter SB; Kastrup J
Biomark Med; 2014; 8(8):977-87. PubMed ID: 25343670
[TBL] [Abstract][Full Text] [Related]
19. The chitinase-like protein YKL-40: a possible biomarker of inflammation and airway remodeling in severe pediatric asthma.
Konradsen JR; James A; Nordlund B; Reinius LE; Söderhäll C; Melén E; Wheelock AM; Lödrup Carlsen KC; Lidegran M; Verhoek M; Boot RG; Dahlén B; Dahlén SE; Hedlin G
J Allergy Clin Immunol; 2013 Aug; 132(2):328-35.e5. PubMed ID: 23628340
[TBL] [Abstract][Full Text] [Related]
20. Serum YKL-40/chitinase 3-like protein 1 level is an independent predictor of atherosclerosis development in patients with obstructive sleep apnea syndrome.
Bakırcı EM; Ünver E; Değirmenci H; Kıvanç T; Günay M; Hamur H; Büyüklü M; Ceyhun G; Topal E; Çoban TA
Turk Kardiyol Dern Ars; 2015 Jun; 43(4):333-9. PubMed ID: 26142786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
